Vivodyne
Vivodyne48
About
What does Vivodyne do?
Vivodyne revolutionizes therapeutics development by providing preclinical human data before clinical trials. Their platform utilizes ultra-realistic, lab-grown human organ tissue models and predictive AI to accelerate the discovery and optimization of new therapies. They partner with biopharma companies to advance new targets and bring better therapeutics to patients.
What is Vivodyne's valuation?
StartupHub estimates Vivodyne's effective valuation at $439.2M (range $295.0M to $708.0M, 18% confidence), based on comparable companies in the sector.
How much funding has Vivodyne raised?
Vivodyne has raised a total of $118M in funding.
Where is Vivodyne headquartered?
Vivodyne is headquartered in New York, United States.
When was Vivodyne founded?
Vivodyne was founded in 2021.
What industry does Vivodyne operate in?
Vivodyne operates in AI Drug Discovery, Biotech, Foundation Model, Generative AI, Drug Discovery, Machine Learning.
How many employees does Vivodyne have?
Vivodyne has approximately 41 people on record.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
Zyvorx is a biotechnology company using AI and computational biology to accelerate drug discovery and development.
An entrant is a company tagged AI Drug Discovery whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.